M Nakashima Selected Research

Carcinoma (Carcinomatosis)

2/2005	Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.
9/2004	Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
3/2004	Expression of Tie-1 and 2 receptors, and angiopoietin-1, 2 and 4 in gastric carcinoma; immunohistochemical analyses and correlation with clinicopathological factors.
7/2001	Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.
7/2001	Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma.
6/2001	RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin.
5/2001	Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
10/2000	Molecular analysis of mechanisms regulating drug sensitivity and the development of new chemotherapy strategies for genitourinary carcinomas.
9/2000	Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
2/2000	Expression of pituitary-tumour transforming gene in colorectal tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Nakashima Research Topics

Disease

29	Neoplasms (Cancer) 01/2016 - 01/2000
10	Carcinoma (Carcinomatosis) 02/2005 - 02/2000
6	Asthma (Bronchial Asthma) 10/2005 - 09/2000
5	Infections 01/2021 - 12/2001
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 09/2000
3	Rheumatoid Arthritis 01/2021 - 08/2000
3	Neoplasm Metastasis (Metastasis) 09/2005 - 02/2000
3	Adenocarcinoma 03/2004 - 11/2000
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 01/2010
2	Inflammation (Inflammations) 01/2021 - 03/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2008
2	Chronic Hepatitis C 04/2018 - 05/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2018 - 02/2001
2	Obesity 06/2016 - 06/2009
2	Hemorrhage 12/2011 - 01/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2006 - 06/2001
2	Emphysema 02/2006 - 10/2004
2	Adenoma (Adenomas) 12/2001 - 05/2001
2	Lymphatic Metastasis 05/2001 - 12/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Xerostomia 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Virus Diseases (Viral Diseases) 04/2018
1	Insulin Resistance 04/2018
1	Epilepsy (Aura) 01/2018
1	Weight Loss (Weight Reduction) 06/2016
1	Overweight 06/2016
1	Kabuki syndrome 01/2016
1	Microcephaly 05/2015
1	Liver Diseases (Liver Disease) 05/2015
1	Seizures (Absence Seizure) 05/2015
1	Keratitis 02/2015
1	Abscess 02/2015
1	Pathologic Constriction (Stenosis) 12/2011
1	Brain Ischemia (Cerebral Ischemia) 07/2011
1	Ischemia 07/2011
1	Breast Neoplasms (Breast Cancer) 03/2011
1	Ductal Carcinoma 03/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Non-alcoholic Fatty Liver Disease 01/2010
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2010
1	Perennial Allergic Rhinitis 12/2008

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 01/2021 - 11/2000
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2000
4	LigandsIBA 03/2004 - 07/2001
3	Messenger RNA (mRNA)IBA 03/2011 - 09/2000
3	EnzymesIBA 01/2010 - 12/2001
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2008 - 08/2000
3	Cisplatin (Platino)FDA LinkGeneric 05/2002 - 05/2000
3	Monoclonal AntibodiesIBA 07/2001 - 11/2000
3	Budesonide (Pulmicort)FDA LinkGeneric 03/2001 - 09/2000
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 11/2005 - 11/2001
2	Procaterol (Pro-Air)IBA 10/2005 - 07/2005
2	Tumor Biomarkers (Tumor Markers)IBA 11/2001 - 01/2001
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2001 - 06/2001
2	PlatinumIBA 12/2000 - 05/2000
2	SteroidsIBA 09/2000 - 09/2000
1	Bevacizumab (Avastin)FDA Link 01/2023
1	regorafenibIBA 01/2023
1	trifluridine tipiracil drug combinationIBA 01/2023
1	AutoantibodiesIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 04/2018
1	Protons (Proton)IBA 04/2018
1	NucleotidesIBA 01/2018
1	AdiponectinIBA 06/2016
1	Histones (Histone)IBA 01/2016
1	Familial apoceruloplasmin deficiencyIBA 05/2015
1	AntibodiesIBA 03/2015
1	MucinsIBA 12/2011
1	Claudin-1IBA 05/2011
1	LDL Receptors (LDL Receptor)IBA 05/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 05/2011
1	OccludinIBA 05/2011
1	Estrogen ReceptorsIBA 03/2011
1	Calgranulin AIBA 03/2011
1	ParaffinIBA 03/2011
1	Gemcitabine FDA Link 01/2011
1	nedaplatinIBA 01/2011
1	CholesterolIBA 01/2010
1	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 01/2010
1	Bile Acids and Salts (Bile Acids)IBA 01/2010
1	BezafibrateIBA 01/2010
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2010
1	PPAR alphaIBA 01/2010
1	Alkaline PhosphataseIBA 01/2010
1	Amiodarone (Amiodarona)FDA LinkGeneric 06/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2008
1	Nasal SpraysIBA 12/2008
1	fluticasone furoate FDA Link 12/2008

Therapy/Procedure

8	Therapeutics 01/2023 - 11/2001
3	Metered Dose Inhalers (Metered Dose Inhaler) 10/2005 - 03/2001
2	Radiotherapy 05/2006 - 01/2000
2	Drug Therapy (Chemotherapy) 10/2000 - 01/2000
1	Cell Transplantation 01/2016
1	Slit Lamp 02/2015
1	Transplantation 07/2011
1	Pulpectomy 07/2011
1	Pulpotomy 07/2011
1	Stem Cell Transplantation 07/2011